NCT03812536 is a NA clinical trial of No Void in Complications, Postoperative, sponsored by Syed Husain.

Who is sponsoring NCT03812536?

NCT03812536 is sponsored by Syed Husain.

What drugs are being tested in NCT03812536?

Interventions in NCT03812536: No Void.

What condition does NCT03812536 study?

NCT03812536 studies Complications, Postoperative.

Is NCT03812536 still recruiting?

NCT03812536 is currently completed. Last updated 13 April 2025.

Are results published for NCT03812536?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-04-13 · How we verify

NCT03812536

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Spontaneous Void Requirements for Patients Undergoing Ambulatory Anorectal Surgery

Completed NA Results posted Last updated 13 April 2025

What this trial tests

NA trial testing No Void in Complications, Postoperative in 104 participants. Completed in 7 August 2020.

Timeline

19 June 2018

Primary endpoint
7 August 2020

7 August 2020

Quick facts

Lead sponsor	Syed Husain
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	104
Start date	19 June 2018
Primary completion	7 August 2020
Estimated completion	7 August 2020
Sites	1 location across United States

Drugs / interventions tested

No Void

Conditions studied

Complications, Postoperative — all drugs for Complications, Postoperative →

Sponsor

Syed Husain

Who can join

Adults 18 to 80, any sex, with Complications, Postoperative. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

PACU Time Primary · This measure will be recorded through the study period.

This is the time patients in each arm spend in recovery. Measured as minutes elapsed between the end of surgery (surgery end time) and discharge from recovery room.

Group	Value	95% CI
SOC Voiding Protocol	129.1	± 100.0
No Void Intervention	210.0	± 175.0

30-day Readmission Secondary · 30 days

Number of patients readmitted in the 30-days period after surgery

Group	Value	95% CI
SOC Voiding Protocol	0
No Void Intervention	0

Sponsor's own description

The objective of this study is to assess if not requiring patients to spontaneous void prior to discharge from the post-anesthesia care unit (PACU) will results in shorter lengths of stay in the post-anesthesia care unit without increasing hospital readmissions or emergency room visits.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Complications, Postoperative

Currently open trials in the same condition.

NCT06820736 — A Prospective, Randomized Comparison Of Drainage Techniques After One- Or Two-Level Open Posterior Lumbar Decompression · NA · recruiting
NCT06527105 — Impact of Sleep Quality on Outcomes After Cardiac Surgery · NA · recruiting
NCT05630443 — Effects of Prone Position After Major Abdominal Surgery · NA · recruiting

Other Syed Husain trials

Trials by the same sponsor.

NCT03813537 — Evaluation of Hospital Readmission Rate Dependent on Post-Operative Follow-Up Procedure · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03812536 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Syed Husain
Last refreshed: 13 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03812536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing